Literature DB >> 16490126

Prisoners favour hepatitis C testing and treatment.

S Vallabhaneni1, G E Macalino, S E Reinert, B Schwartzapfel, F A Wolf, J D Rich.   

Abstract

More people with hepatitis C virus pass through incarcerated settings each year than any other venue. The goal of this study was to assess inmates' attitudes towards hepatitis C testing and treatment while incarcerated. We interviewed 153 male and female inmates at the Rhode Island Department of Corrections (RIDOC). Ninety-one per cent of inmates said they would agree to be tested for hepatitis C and 95% said that they would be willing to be treated for hepatitis C while incarcerated. Thirty-three per cent perceived themselves to be at risk for hepatitis C. Inmates were very interested in hepatitis C testing and, if indicated treatment. Inmates' attitudes towards hepatitis C testing and treatment do not pose a major obstacle to implementing comprehensive hepatitis C screening and treatment programme in correctional settings.

Entities:  

Mesh：

Year:  2006        PMID： 16490126      PMCID： PMC2870391          DOI： 10.1017/S0950268805004991

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN： 0950-2688            Impact factor:   2.451


  14 in total

1.  The importance of routine HIV testing in the incarcerated population: the Rhode Island experience.

Authors:  Amar A Desai; E Timothy Latta; Anne Spaulding; Josiah D Rich; Timothy P Flanigan
Journal:  AIDS Educ Prev       Date:  2002-10

2.  Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons.

Authors:  Grace E Macalino; David Vlahov; Stephanie Sanford-Colby; Sarju Patel; Keith Sabin; Christopher Salas; Josiah D Rich
Journal:  Am J Public Health       Date:  2004-07       Impact factor: 9.308

3.  Hepatitis C in state correctional facilities.

Authors:  A Spaulding; C Greene; K Davidson; M Schneidermann; J Rich
Journal:  Prev Med       Date:  1999-01       Impact factor: 4.018

4.  The burden of infectious disease among inmates of and releasees from US correctional facilities, 1997.

Authors:  Theodore M Hammett; Mary Patricia Harmon; William Rhodes
Journal:  Am J Public Health       Date:  2002-11       Impact factor: 9.308

Review 5.  Hepatitis C and human immunodeficiency virus infection.

Authors:  David L Thomas
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

6.  Hepatitis C disease among injection drug users: knowledge, perceived risk and willingness to receive treatment.

Authors:  M D Stein; J Maksad; J Clarke
Journal:  Drug Alcohol Depend       Date:  2001-02-01       Impact factor: 4.492

7.  Prisoners' attitudes toward Hepatitis B vaccination.

Authors:  Snigdha Vallabhaneni; Grace E Macalino; Steven E Reinert; Beth Schwartzapfel; Francis A Wolf; Josiah D Rich
Journal:  Prev Med       Date:  2004-06       Impact factor: 4.018

8.  Treatment of chronic hepatitis C in a state correctional facility.

Authors:  Scott A Allen; Anne C Spaulding; Albert M Osei; Lynn E Taylor; Asya M Cabral; Josiah D Rich
Journal:  Ann Intern Med       Date:  2003-02-04       Impact factor: 25.391

9.  Hepatitis-associated knowledge is low and risks are high among HIV-aware injection drug users in three US cities.

Authors:  Robert Heimer; Scott Clair; Lauretta E Grau; Ricky N Bluthenthal; Patricia A Marshall; Merrill Singer
Journal:  Addiction       Date:  2002-10       Impact factor: 6.526

10.  Hepatitis C seroprevalence among newly incarcerated inmates in the Texas correctional system.

Authors:  J Baillargeon; H Wu; M J Kelley; J Grady; L Linthicum; K Dunn
Journal:  Public Health       Date:  2003-01       Impact factor: 2.427
View more
  5 in total

1.  Recommendations on hepatitis C screening for adults.

Authors:  Roland Grad; Brett Thombs; Marcello Tonelli; Maria Bacchus; Richard Birtwhistle; Scott Klarenbach; Harminder Singh; Veronique Dorais; Nathalie Holmes; Wendy Martin; Rachel Rodin; Alejandra Jaramillo Garcia
Journal:  CMAJ       Date:  2017-04-24       Impact factor: 8.262

2.  Canadian hepatitis C virus screening guideline: a disconnect between evidence and recommendations.

Authors:  Alex Haines; William W L Wong; Murray Krahn
Journal:  CMAJ       Date:  2017-09-11       Impact factor: 8.262

3.  Treating drug abuse and addiction in the criminal justice system: improving public health and safety.

Authors:  Redonna K Chandler; Bennett W Fletcher; Nora D Volkow
Journal:  JAMA       Date:  2009-01-14       Impact factor: 56.272

4.  Active Case Finding for Communicable Diseases in Prison Settings: Increasing Testing Coverage and Uptake Among the Prison Population in the European Union/European Economic Area.

Authors:  Lara Tavoschi; Hilde Vroling; Giordano Madeddu; Sergio Babudieri; Roberto Monarca; Marije Vonk Noordegraaf-Schouten; Netta Beer; Joana Gomes Dias; Éamonn O'Moore; Dagmar Hedrich; Anouk Oordt-Speets
Journal:  Epidemiol Rev       Date:  2018-06-01       Impact factor: 6.222

5.  Distribution of HCV genotypes in the populations of inmates in polish prison potulice and patients hospitalised in bydgoszcz.

Authors:  Malgorzata Tyczyno; Waldemar Halota; Wojciech Nowak; Małgorzata Pawlowska
Journal:  Hepat Mon       Date:  2014-05-03       Impact factor: 0.660
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.